Eysz

?? November is?Epilepsy Awareness Month, and we’re proud to join the conversation by sharing an excerpt from?AJ on Startups?featuring our Founder, Dr. Rachel Kuperman. In this clip, Rachel sheds light on a challenge faced by many families and healthcare providers: differentiating between?Absence seizures?and symptoms of inattentive-type ADHD. With overlapping behaviors like “zoning out,” it’s no surprise that diagnosis can be complex—but the impact of getting it right is life-changing. ?? At Eysz, we’re on a mission to make it easier to identify brain disorders like Childhood Absence Epilepsy early and accurately. Awareness and innovation go hand in hand to make a difference for patients and their families. ?? Watch the clip below and join us in spreading awareness this November. Together, we can shine a light on epilepsy and the need for better diagnostic tools. #EpilepsyAwarenessMonth #ChildhoodAbsenceEpilepsy #BrainHealth #HealthTech #Innovation #ADHD #Epilepsy

? Thrilled to be featured on?AJ on Startups! ? We’re so pleased our Founder, Dr. Rachel Kuperman, had the opportunity to sit down with AJ Fortier for an insightful conversation about the journey of Eysz and our mission to democratize the diagnosis and monitoring of brain disorders. ???? Thank you, AJ, for highlighting the work we’re doing to revolutionize healthcare through technology. Your dedication to spotlighting startups is inspiring, and it was an honor to share our story with you. If you’re curious about the intersection of health tech, entrepreneurship, and innovation, don’t miss this episode! Watch the full interview here: https://lnkd.in/e6qsSyb7 Or listen to the Podcast AJ on Startups on Spotify or Apple Podcasts! #Startups #HealthTech #Innovation #Entrepreneurship #BrainHealth

We are pleased to announce our collaboration with a new site - Focus-MD Birmingham! We are ready to join Dr. Tanikqua Moore and the rest of the forward-thinking, innovative team in bringing excellent #brainHealth care to children in Birmingham. #Pediatrics #PediatricNeurology #PartnersInCare

We’re excited to announce our collaboration with Alabama Game Changers! By utilizing our solution, Alabama Game Changers is able to reduce wait times to child neurology for their patients and rule out absence seizures in the context of ADHD care. This collaboration supports our commitment to providing clinicians with access to our innovative platform to facilitate timely diagnosis and treatments. #BrainHealth #AlabamaGameChangers #HealthcareInnovation

How are we helping Pediatricians implement the AAP Guidelines on ADHD? At Eysz, we’ve developed a cutting-edge app that standardizes and gamifies hyperventilation, a process to screen for absence seizures. Absence seizures cause many of the same symptoms as ADHD, and are even comorbid with ADHD. Using our app to screen for these similar conditions helps achieve faster access to treatment for patients and more confidence for physicians. Check out this video to see how the Eysz app works and how we’re empowering healthcare professionals with tools that transform patient outcomes. #HealthTech #EpilepsyDiagnosis #PediatricNeurology #DigitalHealth #InnovationInHealthcare #SaMD #MedicalDevices #Eysz

We’re thrilled to announce that our?ACER Study?is officially enrolling at?Atrium Health Wake Forest Baptist,?CHOC Children's, and?Children's Hospital Colorado. This marks a significant step in our research exploring the relationship between epilepsy, attention, and mood using eye movements. Thank you to our partners and collaborators for helping us reach this milestone! Learn more about the ACER Study here: https://lnkd.in/gHFe-SqS #EpilepsyResearch #HealthcareInnovation #NSFGrant #Neurology #ScientificResearch #EpilepsyAwareness #MedicalInnovation #HealthcareResearch

Staring spells are common in both Childhood Absence Epilepsy (CAE) and ADHD, which complicates the diagnosis process. ?? 80% of children with ADHD experience staring spells, but so do 94% of children with CAE. ?? And with 50% of children with CAE also having ADHD, navigating these symptoms requires precision. At Eysz, we’re developing tools to help physicians differentiate and diagnose more accurately, ensuring that children receive the right care, faster. Let’s work together to bring clarity to complex diagnoses. Read the full article on our website: https://lnkd.in/eGh8yneY #HealthTech #EpilepsyAwareness #ADHDAwareness #PediatricNeurology #Epilepsy #MedicalDevices #Eysz #Pediatrics #AAPGuideline

We are pleased to announce that we are partnering with Dr. Shalaka Indulkar and her team at Carolina Child Neurology in Fayetteville, NC! Together, we aim to enhance care for children with epilepsy through innovative solutions. The commitment of Carolina Child Neurology’s dedicated team to providing exceptional treatment options is inspiring. We look forward to collaborating and making a meaningful difference in the lives of young patients! ?? #EpilepsyAwareness #PediatricNeurology #HealthcareInnovation #Collaboration #Eysz #ChildrensHealth

https://lnkd.in/eFnK4wjw ?? Exciting news from the Journal of Child Neurology! Dive into our latest publication: "Hyperventilation Activation in Diagnosis and Management of Childhood Absence Epilepsy" by Dr. Chethan Rao, D.O., M.S. and Eysz' own Dr. Rachel Kuperman. This comprehensive article explores the effectiveness of hyperventilation as a diagnostic and management tool for childhood absence epilepsy, offering insights into streamlining care and improving outcomes for young patients: ???? Childhood Absence Epilepsy (CAE):?A common pediatric epilepsy syndrome, often presenting with brief staring spells (absence seizures) that can go unnoticed, leading to diagnostic delays. ? Hyperventilation in Diagnosis:?Hyperventilation triggers absence seizures in over 90% of patients with CAE, making it a valuable tool for diagnosing the condition. ?? Resource Efficiency:?Many children referred for "staring spells" do not have epilepsy, causing overuse of EEG resources. Hyperventilation testing could help pediatricians more effectively screen patients, reducing unnecessary referrals. ?? Clinical Use:?Hyperventilation is widely used by child neurologists to assess seizure control, and it could improve treatment management by providing real-time data on seizure activity during follow-up visits. ?? Safety and Efficacy:?Hyperventilation is generally safe with minimal risks, though contraindications (e.g., recent stroke, severe cardiopulmonary issues) should be considered. ?? Variability in Practice:?There is significant variability in how Hyperventilation are used in managing CAE, highlighting the need for standardized guidelines to optimize care. ?? Potential for Improved Outcomes:?Using hyperventilation as a screening and management tool could decrease healthcare costs, reduce time to diagnosis, and lead to better patient outcomes by enabling earlier and more accurate intervention. Epilepsy Alliance America Epilepsy Foundation Epilepsy Foundation of Northern California Child Neurology Foundation Pediatric Epilepsy Research Consortium

Thank you, #CTIP !